Artificial intelligence Enabled Diabetic Retinopathy Screening to Meet the Scaling Challenges
The only part of human body where changes in microcirculation can be observed directly and non-invasively, reflecting the development of ocular and systemic diseases.
Designed for scaling up screening services
· Robust performance，· Strong generalization ability，· Good compatibility
Artificial Intelligence AI · Intense focus on optimizing quality, quantity and labeling of the original data (color fundus photographs)，· Proprietary deep neural network model to mitigate over/underfitting，· Extensive self and third-party validation under numerous settings + Reading Center RC Centralized reading center and rigorous three-tier quality control system
· Minimize system risks，· Maximize performance quality